Verification evidence is still being completed.
PDF / print export
Admescope
Oulu, Finland
- Verified lead
- Outi Kontkanen
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- CEO
- 2026 technical specialization
- ADME-Tox, DMPK, Bioanalysis, Drug Discovery Support, and Preclinical CRO Services
- Review cycle
- May 2026
- Full address
- Saaristonkatu 5 C, 90100 Oulu, Finland
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official Admescope contact page confirming the Oulu operating address.
- Editorial note
- Admescope is published because official company materials confirm current leadership, Oulu operating footprint, and a real CRO platform focused on ADME-Tox and bioanalytical drug-development services.
ADME-Tox, DMPK, Bioanalysis, Drug Discovery Support, and Preclinical CRO Services
Official company leadership disclosure, Official Oulu contact disclosure, CRO service-platform claim
Admescope is published because official company materials confirm current leadership, Oulu operating footprint, and a real CRO platform focused on ADME-Tox and bioanalytical drug-development services.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated02 Jun 2026, 01:40
Admescope runs adme-tox services, dmpk studies, and bioanalysis and drug discovery support in Oulu, Finland.
- Lead
- Outi Kontkanen (verified ↗)
- Address
- Saaristonkatu 5 C, 90100 Oulu, Finland (source ↗)
- Compliance
- Not yet on record
- Last reviewed
- 21 Mar 2026 (2mo ago)
- Scale
- Commercial CRO service platform
- Capabilities
- ADME-Tox Services · DMPK Studies · Bioanalysis and Drug Discovery Support
- Founded
- 2009
- Headcount
- 11-50
- Company page (open ↗)
Clinical profileSTATUS: VERIFIED MARCH 2026
Outi Kontkanen
CEO
Full addressSaaristonkatu 5 C, 90100 Oulu, Finland
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
Physical site source
Official Admescope contact page listing the Saaristonkatu 5 C Oulu address.
Open sourceCommercial CRO service platform
Oulu, Finland. ADME-Tox, DMPK, Bioanalysis, Drug Discovery Support, and Preclinical CRO Services. Review completed on 21 Mar 2026.
Finnish corporate governance and preclinical research-service oversight
Official company leadership disclosure, Official Oulu contact disclosure, CRO service-platform claim
ADME-Tox, DMPK, Bioanalysis, Drug Discovery Support, and Preclinical CRO Services
Admescope is published because official company materials confirm current leadership, Oulu operating footprint, and a real CRO platform focused on ADME-Tox and bioanalytical drug-development services.
Editorial note
Admescope is published because official company materials confirm current leadership, Oulu operating footprint, and a real CRO platform focused on ADME-Tox and bioanalytical drug-development services.
FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026
Capabilities
Core capabilities
Primary declared technical activities and areas of operating focus.
ADME-Tox Services
DMPK Studies
Bioanalysis and Drug Discovery Support
Verification source dossier
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Infrastructure
Declared infrastructure
ADME-Tox service platform
Bioanalytical instrumentation
Drug metabolism and DMPK workflow
Regulatory posture
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Verification history
21 Mar 2026: Executive identity confirmed via official management disclosure.
21 Mar 2026: Full trust review completed.
FAQ
Frequently asked questions
- Where is Admescope located?
- Admescope operates from Saaristonkatu 5 C, 90100 Oulu, Finland, Oulu, Finland.
- Who runs Admescope?
- Admescope is led by Outi Kontkanen, CEO. Verified 21 Mar 2026.
- What does Admescope do?
- Admescope runs adme-tox services, dmpk studies, and bioanalysis and drug discovery support in Oulu, Finland. Core capabilities: ADME-Tox Services, DMPK Studies, Bioanalysis and Drug Discovery Support.
Editorial context
Related technical briefs
Briefs that name Oulu as a covered market or city.